"Running Is No Longer Just a Muscle Game. Now It Is the Powered Footwear Market."

The definition of athletic shoes has changed. Nike "Project Amplify" unveiled in October 2025 does not belong to the conventional running shoe category -- Nike defines this product as "the world first powered assistive footwear system." The core is clear: a wearable powered assistance device enabling running, jogging, and walking to go further, faster, with less energy. The system is designed so a "shoe + robot" substitutes for some of the work done by calf muscles -- in Nike internal terms, "your second set of calf muscles." Nike emphasizes this technology is NOT doping-type equipment for elite marathon record-breaking. Rather the opposite: designed for "everyday bodies" -- casual runners who tire easily (10-12 minute mile pace), office workers who want to switch commute distance to walking, people with heavy knee/ankle burden on hills, those in injury recovery or with reduced mobility. Technical architecture: foot-mounted actuator system with sensors in the insole detecting gait phase (stance vs. swing), controlling powered carbon-fiber strut that actively assists push-off; Bluetooth-connected mobile app for personalization; rechargeable battery lasting a full marathon distance. Weight approximately 500g per shoe -- heavier than traditional running shoes but the system compensates through power assistance. Target market positioning: Nike is positioning Project Amplify not in the elite performance segment but in the "aging active population" and "mobility assistance" segments -- potentially including medical device market overlap with prescription-level mobility assistance. The regulatory complexity: if the device provides therapeutic benefit (helping people with mobility impairment walk further), FDA medical device approval may be required; if positioned purely as athletic equipment, existing sporting goods regulations apply.